Cirrhosis and Hepatocellular Carcinoma in a Patient with Heterozygous (MZ) Alpha-1 -Antitrypsin Deficiency

References

• Tobin M J, Hutchinson D C. An overview of the pulmonary features of a 1 antitrypsin deficiency. Arch Intern Med 1982; 142: 1342–8
   PubMedGoogle Scholar
• Fagerhol M K. The genetics of α 1 antitrypsin and its implications. Postgrad Med J 1976; 52(Suppl 2)73–83
   PubMedGoogle Scholar
• Clark P. Alpha-1-Protease inhibitor phenotypes in Australia. Hum Hered 1982; 32: 225–7
   PubMedGoogle Scholar
• Morse J O, Lebowitz M D, Knudson R J, Burrows B. Relation of Protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 1977; 296: 1190–4
   PubMed Web of Science ®Google Scholar
• Sharp H L, Bridges R A, Krivit W, Frier E G. Cirrhosis associated with α 1 antitrypsin deficiency: a previously unrecognised inherited disorder. J Lab Clin Med 1969; 73: 934–9
   PubMed Web of Science ®Google Scholar
• Eriksson S. Pulmonary emphysema and α 1 antitrypsin deficiency. Acta Med Scand 1964; 175: 197–205
   PubMed Web of Science ®Google Scholar
• Berg N, Eriksson S. Liver disease in adults with α 1 antitrypsin deficiency. N Engl J Med 1972; 287: 1264–7
   PubMed Web of Science ®Google Scholar
• Eriksson S, Hagerstrand I. Cirrhosis and malignant hepatoma in α 1 antitrypsin deficiency. Acta Med Scand 1974; 195: 451–8
   PubMed Web of Science ®Google Scholar
• Schleissner L A, Cohen A J. Alpha 1 antitrypsin deficiency and hepatic carcinoma. Am Rev Respir Dis 1974; 111: 863–8
   Google Scholar
• Rawlings W, Moss J, Cooper H S, Hamilton S R. Hepatocellular carcinoma and partial deficiency of α 1 antitrypsin (MZ). Ann Intern Med 1974; 81: 771–3
   PubMed Web of Science ®Google Scholar
• Hodges J R, Millward-Sadler G H, Barbatis C, Wright R. Heterozygous (MZ) alpha-1-antitrypsin deficiency in adults with chronic hepatitis and cryptogenic cirrhosis. N Engl J Med 1981; 34: 557–60
   Google Scholar
• Campra J L, Craig J R, Peters R L, Reynolds T B. Cirrhosis associated with partial deficiency of alpha-1-antitrypsin in an adult. Ann Intern Med 1973; 78: 233–8
   PubMed Web of Science ®Google Scholar
• Eriksson S, Moestrup T, Hagerstrand I. Liver, lung and malignant disease in heterozygous (Pi MZ) α 1 antitrypsin deficiency. Acta Med Scand 1975; 198: 243–7
   PubMedGoogle Scholar
• Fisher R L, Taylor L, Sherlock S. Alpha-1-antitrypsin deficiency in liver disease: the extent of the problem. Gastroenterology 1976; 71: 646–51
   PubMed Web of Science ®Google Scholar
• Morin T, Feldman G, Benhamou J P, et al. Heterozygous alpha-1-antitrypsin deficiency and cirrhosis — a fortuitous association. Lancet 1975; 1: 250–1
   PubMed Web of Science ®Google Scholar
• Theodoropoulos G, Fertakis A, Archimandritis A. Alpha-1-antitrypsin phenotypes in cirrhosis and hepatoma. Acta Hepatico Gastroenterol 1976; 23: 114–7
   Google Scholar
• Lieberman J. Emphysema, cirrhosis and alpha-1-antitrypsin deficiency. Ann Intern Med 1974; 81: 850
   PubMed Web of Science ®Google Scholar
• Lieberman J, Silton R M, Agliozzo C M, McMahon J. Hepatocellular carcinoma and intermediate alpha-1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol 1975; 64: 304–10
   PubMed Web of Science ®Google Scholar
• Rubel L R, Ishak K G, Benjamin S B, Knuff T E. Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Arch Pathol Lab Med 1982; 106: 678–81
   Google Scholar
• Reintoft I, Hagerstrand I E. Does the Z gene variant of alpha-1-antitrypsin predispose to hepatic carcinoma. Hum Pathol 1979; 10: 419–24
   Google Scholar
• Fargion S, Klasen E C, Lalatta F, et al. Alpha-1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis. Clin Genet 1981; 19: 134–9
   Google Scholar
• Chan C H, Steer C J, Vergalla J, Jones E A. Alpha-1-antitrypsin deficiency with cirrhosis associated with protease inhibitor phenotype SZ. Am J Med 1978; 65: 978–86
   Google Scholar
• Kew M C, Turnbull R, Prinsloo I. Alpha-1-antitrypsin deficiency and hepatocellular cancer. Br J Cancer 1978; 37: 635–8
   Google Scholar
• Govindarajan S, Ashcavai I, Peters R L. Alpha-1-antitrypsin phenotypes and hepatocellular carcinoma. Hepatology 1981; 1: 628–31
   Google Scholar
• Craig J R, Peters R L, Edmonson H A. Fibrolamellar carcinoma: a tumor of adolescents and young adults with distinctive clinico-pathological features. Cancer 1980; 46: 372–9
   PubMed Web of Science ®Google Scholar
• Pariente E-A, Degott C, Martin J-P, et al. Hepatocystic PAS-positive diastase-resistant inclusions in the absence of alpha-1-antitrypsin deficiency: High prevalence in alcoholic cirrhosis. Am J Clin Pathol 1981; 76: 299–302
   Google Scholar
• Bradfield W B, Blenkinsopp W K. Alpha-1-antitrypsin globules in the liver and PiM phenotype. J Clin Pathol 1977; 30: 464–6
   Google Scholar
• Kew M C, Geddes E W, MacNab G M, Bersohn I. Hepatitis B antigen and cirrhosis in Bantu patients with primary liver cancer. Cancer 1974; 34: 539–41
   Web of Science ®Google Scholar
• Kelly J K, Davies J S, Jones A W. Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. J Clin Pathol 1979; 32: 373–6
   Google Scholar
• Roth J A, Befeler D, Berman E, Johnson F B. A black hepatocellular carcinoma with Dubin-Johnson like pigment and Mallory bodies. Am J Surg Pathol 1982; 6: 375–82
   Google Scholar
• Palmer P E, Wolfe H J. Alpha-1-antitrypsin deposition in primary hepatic carcinomas. Arch Pathol Lab Med 1976; 10: 232–6
   Google Scholar
• Callea F, Ray M B, Desmet V J. Alpha-1-antitrypsin and copper in the liver. Histopathology 1981; 5: 415–24
   Google Scholar
• French S W, Burbige E J. Alcoholic hepatitis; clinical morphologic, pathogenic and therapeutic aspects. Progress in liver diseases, H Popper, F Schaffner. Grune & Stratton, New York 1979; vol 6: 557–79
   Google Scholar
• Norkin S A, Campagna-Pinto D. Cytoplasmic hyaline inclusions in hepatoma — a histochemical study. Arch Pathol 1968; 86: 25–32
   PubMedGoogle Scholar
• Triger D R, Millward-Sadler G H, Czaykowski A A. Alpha-1-antitrypsin deficiency and liver disease in adults. Q J Med 1976; 45: 351–72
   Google Scholar